CLINICAL_TRIALS
trial_result
· 2020-04-13
Clinical Trial Update: A 26-Week Study to Evaluate the Efficacy and Safety of Tenapanor in IBS-C [Phase 3]
Summary
Phase 3 trial evaluating tenapanor for constipation-predominant irritable bowel syndrome has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ardelyx | Conditions: Constipation Predominant Irritable Bowel Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2020-04-13